Global Long-acting Anti-HIV Drug Supply, Demand and Key Producers, 2024-2030
The global Long-acting Anti-HIV Drug market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
Long-acting anti-HIV drugs provide effective treatment options for HIV-infected people and have been widely recognized by the market. With the continuous deepening of research and development and the growth of market demand, long-acting anti-HIV drugs are expected to play a greater role in the future.
This report studies the global Long-acting Anti-HIV Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Long-acting Anti-HIV Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Long-acting Anti-HIV Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Long-acting Anti-HIV Drug total production and demand, 2019-2030, (K Units)
Global Long-acting Anti-HIV Drug total production value, 2019-2030, (USD Million)
Global Long-acting Anti-HIV Drug production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Long-acting Anti-HIV Drug consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Long-acting Anti-HIV Drug domestic production, consumption, key domestic manufacturers and share
Global Long-acting Anti-HIV Drug production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Long-acting Anti-HIV Drug production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Long-acting Anti-HIV Drug production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Long-acting Anti-HIV Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gilead, ViiV Healthcare, Janssen, Tibotec, Cipla and Frontier Biopharmaceutical (Nanjing) Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Long-acting Anti-HIV Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Long-acting Anti-HIV Drug Market, By Region:
1. How big is the global Long-acting Anti-HIV Drug market?
2. What is the demand of the global Long-acting Anti-HIV Drug market?
3. What is the year over year growth of the global Long-acting Anti-HIV Drug market?
4. What is the production and production value of the global Long-acting Anti-HIV Drug market?
5. Who are the key producers in the global Long-acting Anti-HIV Drug market?
Long-acting anti-HIV drugs provide effective treatment options for HIV-infected people and have been widely recognized by the market. With the continuous deepening of research and development and the growth of market demand, long-acting anti-HIV drugs are expected to play a greater role in the future.
This report studies the global Long-acting Anti-HIV Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Long-acting Anti-HIV Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Long-acting Anti-HIV Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Long-acting Anti-HIV Drug total production and demand, 2019-2030, (K Units)
Global Long-acting Anti-HIV Drug total production value, 2019-2030, (USD Million)
Global Long-acting Anti-HIV Drug production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Long-acting Anti-HIV Drug consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Long-acting Anti-HIV Drug domestic production, consumption, key domestic manufacturers and share
Global Long-acting Anti-HIV Drug production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Long-acting Anti-HIV Drug production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Long-acting Anti-HIV Drug production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Long-acting Anti-HIV Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gilead, ViiV Healthcare, Janssen, Tibotec, Cipla and Frontier Biopharmaceutical (Nanjing) Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Long-acting Anti-HIV Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Long-acting Anti-HIV Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- CAB Long-acting Injection
- RPV Long-acting Injection
- Hospital
- Clinic
- Others
- Gilead
- ViiV Healthcare
- Janssen
- Tibotec
- Cipla
- Frontier Biopharmaceutical (Nanjing) Co., Ltd.
1. How big is the global Long-acting Anti-HIV Drug market?
2. What is the demand of the global Long-acting Anti-HIV Drug market?
3. What is the year over year growth of the global Long-acting Anti-HIV Drug market?
4. What is the production and production value of the global Long-acting Anti-HIV Drug market?
5. Who are the key producers in the global Long-acting Anti-HIV Drug market?
1 SUPPLY SUMMARY
1.1 Long-acting Anti-HIV Drug Introduction
1.2 World Long-acting Anti-HIV Drug Supply & Forecast
1.2.1 World Long-acting Anti-HIV Drug Production Value (2019 & 2023 & 2030)
1.2.2 World Long-acting Anti-HIV Drug Production (2019-2030)
1.2.3 World Long-acting Anti-HIV Drug Pricing Trends (2019-2030)
1.3 World Long-acting Anti-HIV Drug Production by Region (Based on Production Site)
1.3.1 World Long-acting Anti-HIV Drug Production Value by Region (2019-2030)
1.3.2 World Long-acting Anti-HIV Drug Production by Region (2019-2030)
1.3.3 World Long-acting Anti-HIV Drug Average Price by Region (2019-2030)
1.3.4 North America Long-acting Anti-HIV Drug Production (2019-2030)
1.3.5 Europe Long-acting Anti-HIV Drug Production (2019-2030)
1.3.6 China Long-acting Anti-HIV Drug Production (2019-2030)
1.3.7 Japan Long-acting Anti-HIV Drug Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Long-acting Anti-HIV Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Long-acting Anti-HIV Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Long-acting Anti-HIV Drug Demand (2019-2030)
2.2 World Long-acting Anti-HIV Drug Consumption by Region
2.2.1 World Long-acting Anti-HIV Drug Consumption by Region (2019-2024)
2.2.2 World Long-acting Anti-HIV Drug Consumption Forecast by Region (2025-2030)
2.3 United States Long-acting Anti-HIV Drug Consumption (2019-2030)
2.4 China Long-acting Anti-HIV Drug Consumption (2019-2030)
2.5 Europe Long-acting Anti-HIV Drug Consumption (2019-2030)
2.6 Japan Long-acting Anti-HIV Drug Consumption (2019-2030)
2.7 South Korea Long-acting Anti-HIV Drug Consumption (2019-2030)
2.8 ASEAN Long-acting Anti-HIV Drug Consumption (2019-2030)
2.9 India Long-acting Anti-HIV Drug Consumption (2019-2030)
3 WORLD LONG-ACTING ANTI-HIV DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Long-acting Anti-HIV Drug Production Value by Manufacturer (2019-2024)
3.2 World Long-acting Anti-HIV Drug Production by Manufacturer (2019-2024)
3.3 World Long-acting Anti-HIV Drug Average Price by Manufacturer (2019-2024)
3.4 Long-acting Anti-HIV Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Long-acting Anti-HIV Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Long-acting Anti-HIV Drug in 2023
3.5.3 Global Concentration Ratios (CR8) for Long-acting Anti-HIV Drug in 2023
3.6 Long-acting Anti-HIV Drug Market: Overall Company Footprint Analysis
3.6.1 Long-acting Anti-HIV Drug Market: Region Footprint
3.6.2 Long-acting Anti-HIV Drug Market: Company Product Type Footprint
3.6.3 Long-acting Anti-HIV Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Long-acting Anti-HIV Drug Production Value Comparison
4.1.1 United States VS China: Long-acting Anti-HIV Drug Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Long-acting Anti-HIV Drug Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Long-acting Anti-HIV Drug Production Comparison
4.2.1 United States VS China: Long-acting Anti-HIV Drug Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Long-acting Anti-HIV Drug Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Long-acting Anti-HIV Drug Consumption Comparison
4.3.1 United States VS China: Long-acting Anti-HIV Drug Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Long-acting Anti-HIV Drug Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Long-acting Anti-HIV Drug Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Long-acting Anti-HIV Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Long-acting Anti-HIV Drug Production Value (2019-2024)
4.4.3 United States Based Manufacturers Long-acting Anti-HIV Drug Production (2019-2024)
4.5 China Based Long-acting Anti-HIV Drug Manufacturers and Market Share
4.5.1 China Based Long-acting Anti-HIV Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Long-acting Anti-HIV Drug Production Value (2019-2024)
4.5.3 China Based Manufacturers Long-acting Anti-HIV Drug Production (2019-2024)
4.6 Rest of World Based Long-acting Anti-HIV Drug Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Long-acting Anti-HIV Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Long-acting Anti-HIV Drug Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Long-acting Anti-HIV Drug Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Long-acting Anti-HIV Drug Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 CAB Long-acting Injection
5.2.2 RPV Long-acting Injection
5.3 Market Segment by Type
5.3.1 World Long-acting Anti-HIV Drug Production by Type (2019-2030)
5.3.2 World Long-acting Anti-HIV Drug Production Value by Type (2019-2030)
5.3.3 World Long-acting Anti-HIV Drug Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Long-acting Anti-HIV Drug Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Long-acting Anti-HIV Drug Production by Application (2019-2030)
6.3.2 World Long-acting Anti-HIV Drug Production Value by Application (2019-2030)
6.3.3 World Long-acting Anti-HIV Drug Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Gilead
7.1.1 Gilead Details
7.1.2 Gilead Major Business
7.1.3 Gilead Long-acting Anti-HIV Drug Product and Services
7.1.4 Gilead Long-acting Anti-HIV Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Gilead Recent Developments/Updates
7.1.6 Gilead Competitive Strengths & Weaknesses
7.2 ViiV Healthcare
7.2.1 ViiV Healthcare Details
7.2.2 ViiV Healthcare Major Business
7.2.3 ViiV Healthcare Long-acting Anti-HIV Drug Product and Services
7.2.4 ViiV Healthcare Long-acting Anti-HIV Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 ViiV Healthcare Recent Developments/Updates
7.2.6 ViiV Healthcare Competitive Strengths & Weaknesses
7.3 Janssen
7.3.1 Janssen Details
7.3.2 Janssen Major Business
7.3.3 Janssen Long-acting Anti-HIV Drug Product and Services
7.3.4 Janssen Long-acting Anti-HIV Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Janssen Recent Developments/Updates
7.3.6 Janssen Competitive Strengths & Weaknesses
7.4 Tibotec
7.4.1 Tibotec Details
7.4.2 Tibotec Major Business
7.4.3 Tibotec Long-acting Anti-HIV Drug Product and Services
7.4.4 Tibotec Long-acting Anti-HIV Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Tibotec Recent Developments/Updates
7.4.6 Tibotec Competitive Strengths & Weaknesses
7.5 Cipla
7.5.1 Cipla Details
7.5.2 Cipla Major Business
7.5.3 Cipla Long-acting Anti-HIV Drug Product and Services
7.5.4 Cipla Long-acting Anti-HIV Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Cipla Recent Developments/Updates
7.5.6 Cipla Competitive Strengths & Weaknesses
7.6 Frontier Biopharmaceutical (Nanjing) Co., Ltd.
7.6.1 Frontier Biopharmaceutical (Nanjing) Co., Ltd. Details
7.6.2 Frontier Biopharmaceutical (Nanjing) Co., Ltd. Major Business
7.6.3 Frontier Biopharmaceutical (Nanjing) Co., Ltd. Long-acting Anti-HIV Drug Product and Services
7.6.4 Frontier Biopharmaceutical (Nanjing) Co., Ltd. Long-acting Anti-HIV Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Frontier Biopharmaceutical (Nanjing) Co., Ltd. Recent Developments/Updates
7.6.6 Frontier Biopharmaceutical (Nanjing) Co., Ltd. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Long-acting Anti-HIV Drug Industry Chain
8.2 Long-acting Anti-HIV Drug Upstream Analysis
8.2.1 Long-acting Anti-HIV Drug Core Raw Materials
8.2.2 Main Manufacturers of Long-acting Anti-HIV Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Long-acting Anti-HIV Drug Production Mode
8.6 Long-acting Anti-HIV Drug Procurement Model
8.7 Long-acting Anti-HIV Drug Industry Sales Model and Sales Channels
8.7.1 Long-acting Anti-HIV Drug Sales Model
8.7.2 Long-acting Anti-HIV Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Long-acting Anti-HIV Drug Introduction
1.2 World Long-acting Anti-HIV Drug Supply & Forecast
1.2.1 World Long-acting Anti-HIV Drug Production Value (2019 & 2023 & 2030)
1.2.2 World Long-acting Anti-HIV Drug Production (2019-2030)
1.2.3 World Long-acting Anti-HIV Drug Pricing Trends (2019-2030)
1.3 World Long-acting Anti-HIV Drug Production by Region (Based on Production Site)
1.3.1 World Long-acting Anti-HIV Drug Production Value by Region (2019-2030)
1.3.2 World Long-acting Anti-HIV Drug Production by Region (2019-2030)
1.3.3 World Long-acting Anti-HIV Drug Average Price by Region (2019-2030)
1.3.4 North America Long-acting Anti-HIV Drug Production (2019-2030)
1.3.5 Europe Long-acting Anti-HIV Drug Production (2019-2030)
1.3.6 China Long-acting Anti-HIV Drug Production (2019-2030)
1.3.7 Japan Long-acting Anti-HIV Drug Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Long-acting Anti-HIV Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Long-acting Anti-HIV Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Long-acting Anti-HIV Drug Demand (2019-2030)
2.2 World Long-acting Anti-HIV Drug Consumption by Region
2.2.1 World Long-acting Anti-HIV Drug Consumption by Region (2019-2024)
2.2.2 World Long-acting Anti-HIV Drug Consumption Forecast by Region (2025-2030)
2.3 United States Long-acting Anti-HIV Drug Consumption (2019-2030)
2.4 China Long-acting Anti-HIV Drug Consumption (2019-2030)
2.5 Europe Long-acting Anti-HIV Drug Consumption (2019-2030)
2.6 Japan Long-acting Anti-HIV Drug Consumption (2019-2030)
2.7 South Korea Long-acting Anti-HIV Drug Consumption (2019-2030)
2.8 ASEAN Long-acting Anti-HIV Drug Consumption (2019-2030)
2.9 India Long-acting Anti-HIV Drug Consumption (2019-2030)
3 WORLD LONG-ACTING ANTI-HIV DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Long-acting Anti-HIV Drug Production Value by Manufacturer (2019-2024)
3.2 World Long-acting Anti-HIV Drug Production by Manufacturer (2019-2024)
3.3 World Long-acting Anti-HIV Drug Average Price by Manufacturer (2019-2024)
3.4 Long-acting Anti-HIV Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Long-acting Anti-HIV Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Long-acting Anti-HIV Drug in 2023
3.5.3 Global Concentration Ratios (CR8) for Long-acting Anti-HIV Drug in 2023
3.6 Long-acting Anti-HIV Drug Market: Overall Company Footprint Analysis
3.6.1 Long-acting Anti-HIV Drug Market: Region Footprint
3.6.2 Long-acting Anti-HIV Drug Market: Company Product Type Footprint
3.6.3 Long-acting Anti-HIV Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Long-acting Anti-HIV Drug Production Value Comparison
4.1.1 United States VS China: Long-acting Anti-HIV Drug Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Long-acting Anti-HIV Drug Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Long-acting Anti-HIV Drug Production Comparison
4.2.1 United States VS China: Long-acting Anti-HIV Drug Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Long-acting Anti-HIV Drug Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Long-acting Anti-HIV Drug Consumption Comparison
4.3.1 United States VS China: Long-acting Anti-HIV Drug Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Long-acting Anti-HIV Drug Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Long-acting Anti-HIV Drug Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Long-acting Anti-HIV Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Long-acting Anti-HIV Drug Production Value (2019-2024)
4.4.3 United States Based Manufacturers Long-acting Anti-HIV Drug Production (2019-2024)
4.5 China Based Long-acting Anti-HIV Drug Manufacturers and Market Share
4.5.1 China Based Long-acting Anti-HIV Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Long-acting Anti-HIV Drug Production Value (2019-2024)
4.5.3 China Based Manufacturers Long-acting Anti-HIV Drug Production (2019-2024)
4.6 Rest of World Based Long-acting Anti-HIV Drug Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Long-acting Anti-HIV Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Long-acting Anti-HIV Drug Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Long-acting Anti-HIV Drug Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Long-acting Anti-HIV Drug Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 CAB Long-acting Injection
5.2.2 RPV Long-acting Injection
5.3 Market Segment by Type
5.3.1 World Long-acting Anti-HIV Drug Production by Type (2019-2030)
5.3.2 World Long-acting Anti-HIV Drug Production Value by Type (2019-2030)
5.3.3 World Long-acting Anti-HIV Drug Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Long-acting Anti-HIV Drug Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Long-acting Anti-HIV Drug Production by Application (2019-2030)
6.3.2 World Long-acting Anti-HIV Drug Production Value by Application (2019-2030)
6.3.3 World Long-acting Anti-HIV Drug Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Gilead
7.1.1 Gilead Details
7.1.2 Gilead Major Business
7.1.3 Gilead Long-acting Anti-HIV Drug Product and Services
7.1.4 Gilead Long-acting Anti-HIV Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Gilead Recent Developments/Updates
7.1.6 Gilead Competitive Strengths & Weaknesses
7.2 ViiV Healthcare
7.2.1 ViiV Healthcare Details
7.2.2 ViiV Healthcare Major Business
7.2.3 ViiV Healthcare Long-acting Anti-HIV Drug Product and Services
7.2.4 ViiV Healthcare Long-acting Anti-HIV Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 ViiV Healthcare Recent Developments/Updates
7.2.6 ViiV Healthcare Competitive Strengths & Weaknesses
7.3 Janssen
7.3.1 Janssen Details
7.3.2 Janssen Major Business
7.3.3 Janssen Long-acting Anti-HIV Drug Product and Services
7.3.4 Janssen Long-acting Anti-HIV Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Janssen Recent Developments/Updates
7.3.6 Janssen Competitive Strengths & Weaknesses
7.4 Tibotec
7.4.1 Tibotec Details
7.4.2 Tibotec Major Business
7.4.3 Tibotec Long-acting Anti-HIV Drug Product and Services
7.4.4 Tibotec Long-acting Anti-HIV Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Tibotec Recent Developments/Updates
7.4.6 Tibotec Competitive Strengths & Weaknesses
7.5 Cipla
7.5.1 Cipla Details
7.5.2 Cipla Major Business
7.5.3 Cipla Long-acting Anti-HIV Drug Product and Services
7.5.4 Cipla Long-acting Anti-HIV Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Cipla Recent Developments/Updates
7.5.6 Cipla Competitive Strengths & Weaknesses
7.6 Frontier Biopharmaceutical (Nanjing) Co., Ltd.
7.6.1 Frontier Biopharmaceutical (Nanjing) Co., Ltd. Details
7.6.2 Frontier Biopharmaceutical (Nanjing) Co., Ltd. Major Business
7.6.3 Frontier Biopharmaceutical (Nanjing) Co., Ltd. Long-acting Anti-HIV Drug Product and Services
7.6.4 Frontier Biopharmaceutical (Nanjing) Co., Ltd. Long-acting Anti-HIV Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Frontier Biopharmaceutical (Nanjing) Co., Ltd. Recent Developments/Updates
7.6.6 Frontier Biopharmaceutical (Nanjing) Co., Ltd. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Long-acting Anti-HIV Drug Industry Chain
8.2 Long-acting Anti-HIV Drug Upstream Analysis
8.2.1 Long-acting Anti-HIV Drug Core Raw Materials
8.2.2 Main Manufacturers of Long-acting Anti-HIV Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Long-acting Anti-HIV Drug Production Mode
8.6 Long-acting Anti-HIV Drug Procurement Model
8.7 Long-acting Anti-HIV Drug Industry Sales Model and Sales Channels
8.7.1 Long-acting Anti-HIV Drug Sales Model
8.7.2 Long-acting Anti-HIV Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Long-acting Anti-HIV Drug Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Long-acting Anti-HIV Drug Production Value by Region (2019-2024) & (USD Million)
Table 3. World Long-acting Anti-HIV Drug Production Value by Region (2025-2030) & (USD Million)
Table 4. World Long-acting Anti-HIV Drug Production Value Market Share by Region (2019-2024)
Table 5. World Long-acting Anti-HIV Drug Production Value Market Share by Region (2025-2030)
Table 6. World Long-acting Anti-HIV Drug Production by Region (2019-2024) & (K Units)
Table 7. World Long-acting Anti-HIV Drug Production by Region (2025-2030) & (K Units)
Table 8. World Long-acting Anti-HIV Drug Production Market Share by Region (2019-2024)
Table 9. World Long-acting Anti-HIV Drug Production Market Share by Region (2025-2030)
Table 10. World Long-acting Anti-HIV Drug Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Long-acting Anti-HIV Drug Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Long-acting Anti-HIV Drug Major Market Trends
Table 13. World Long-acting Anti-HIV Drug Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Long-acting Anti-HIV Drug Consumption by Region (2019-2024) & (K Units)
Table 15. World Long-acting Anti-HIV Drug Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Long-acting Anti-HIV Drug Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Long-acting Anti-HIV Drug Producers in 2023
Table 18. World Long-acting Anti-HIV Drug Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Long-acting Anti-HIV Drug Producers in 2023
Table 20. World Long-acting Anti-HIV Drug Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Long-acting Anti-HIV Drug Company Evaluation Quadrant
Table 22. World Long-acting Anti-HIV Drug Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Long-acting Anti-HIV Drug Production Site of Key Manufacturer
Table 24. Long-acting Anti-HIV Drug Market: Company Product Type Footprint
Table 25. Long-acting Anti-HIV Drug Market: Company Product Application Footprint
Table 26. Long-acting Anti-HIV Drug Competitive Factors
Table 27. Long-acting Anti-HIV Drug New Entrant and Capacity Expansion Plans
Table 28. Long-acting Anti-HIV Drug Mergers & Acquisitions Activity
Table 29. United States VS China Long-acting Anti-HIV Drug Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Long-acting Anti-HIV Drug Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Long-acting Anti-HIV Drug Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Long-acting Anti-HIV Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Long-acting Anti-HIV Drug Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Long-acting Anti-HIV Drug Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Long-acting Anti-HIV Drug Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Long-acting Anti-HIV Drug Production Market Share (2019-2024)
Table 37. China Based Long-acting Anti-HIV Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Long-acting Anti-HIV Drug Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Long-acting Anti-HIV Drug Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Long-acting Anti-HIV Drug Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Long-acting Anti-HIV Drug Production Market Share (2019-2024)
Table 42. Rest of World Based Long-acting Anti-HIV Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Long-acting Anti-HIV Drug Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Long-acting Anti-HIV Drug Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Long-acting Anti-HIV Drug Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Long-acting Anti-HIV Drug Production Market Share (2019-2024)
Table 47. World Long-acting Anti-HIV Drug Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Long-acting Anti-HIV Drug Production by Type (2019-2024) & (K Units)
Table 49. World Long-acting Anti-HIV Drug Production by Type (2025-2030) & (K Units)
Table 50. World Long-acting Anti-HIV Drug Production Value by Type (2019-2024) & (USD Million)
Table 51. World Long-acting Anti-HIV Drug Production Value by Type (2025-2030) & (USD Million)
Table 52. World Long-acting Anti-HIV Drug Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Long-acting Anti-HIV Drug Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Long-acting Anti-HIV Drug Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Long-acting Anti-HIV Drug Production by Application (2019-2024) & (K Units)
Table 56. World Long-acting Anti-HIV Drug Production by Application (2025-2030) & (K Units)
Table 57. World Long-acting Anti-HIV Drug Production Value by Application (2019-2024) & (USD Million)
Table 58. World Long-acting Anti-HIV Drug Production Value by Application (2025-2030) & (USD Million)
Table 59. World Long-acting Anti-HIV Drug Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Long-acting Anti-HIV Drug Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Gilead Basic Information, Manufacturing Base and Competitors
Table 62. Gilead Major Business
Table 63. Gilead Long-acting Anti-HIV Drug Product and Services
Table 64. Gilead Long-acting Anti-HIV Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Gilead Recent Developments/Updates
Table 66. Gilead Competitive Strengths & Weaknesses
Table 67. ViiV Healthcare Basic Information, Manufacturing Base and Competitors
Table 68. ViiV Healthcare Major Business
Table 69. ViiV Healthcare Long-acting Anti-HIV Drug Product and Services
Table 70. ViiV Healthcare Long-acting Anti-HIV Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. ViiV Healthcare Recent Developments/Updates
Table 72. ViiV Healthcare Competitive Strengths & Weaknesses
Table 73. Janssen Basic Information, Manufacturing Base and Competitors
Table 74. Janssen Major Business
Table 75. Janssen Long-acting Anti-HIV Drug Product and Services
Table 76. Janssen Long-acting Anti-HIV Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Janssen Recent Developments/Updates
Table 78. Janssen Competitive Strengths & Weaknesses
Table 79. Tibotec Basic Information, Manufacturing Base and Competitors
Table 80. Tibotec Major Business
Table 81. Tibotec Long-acting Anti-HIV Drug Product and Services
Table 82. Tibotec Long-acting Anti-HIV Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Tibotec Recent Developments/Updates
Table 84. Tibotec Competitive Strengths & Weaknesses
Table 85. Cipla Basic Information, Manufacturing Base and Competitors
Table 86. Cipla Major Business
Table 87. Cipla Long-acting Anti-HIV Drug Product and Services
Table 88. Cipla Long-acting Anti-HIV Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Cipla Recent Developments/Updates
Table 90. Frontier Biopharmaceutical (Nanjing) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 91. Frontier Biopharmaceutical (Nanjing) Co., Ltd. Major Business
Table 92. Frontier Biopharmaceutical (Nanjing) Co., Ltd. Long-acting Anti-HIV Drug Product and Services
Table 93. Frontier Biopharmaceutical (Nanjing) Co., Ltd. Long-acting Anti-HIV Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Global Key Players of Long-acting Anti-HIV Drug Upstream (Raw Materials)
Table 95. Long-acting Anti-HIV Drug Typical Customers
Table 96. Long-acting Anti-HIV Drug Typical Distributors
LIST OF FIGURE
Figure 1. Long-acting Anti-HIV Drug Picture
Figure 2. World Long-acting Anti-HIV Drug Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Long-acting Anti-HIV Drug Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Long-acting Anti-HIV Drug Production (2019-2030) & (K Units)
Figure 5. World Long-acting Anti-HIV Drug Average Price (2019-2030) & (US$/Unit)
Figure 6. World Long-acting Anti-HIV Drug Production Value Market Share by Region (2019-2030)
Figure 7. World Long-acting Anti-HIV Drug Production Market Share by Region (2019-2030)
Figure 8. North America Long-acting Anti-HIV Drug Production (2019-2030) & (K Units)
Figure 9. Europe Long-acting Anti-HIV Drug Production (2019-2030) & (K Units)
Figure 10. China Long-acting Anti-HIV Drug Production (2019-2030) & (K Units)
Figure 11. Japan Long-acting Anti-HIV Drug Production (2019-2030) & (K Units)
Figure 12. Long-acting Anti-HIV Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Long-acting Anti-HIV Drug Consumption (2019-2030) & (K Units)
Figure 15. World Long-acting Anti-HIV Drug Consumption Market Share by Region (2019-2030)
Figure 16. United States Long-acting Anti-HIV Drug Consumption (2019-2030) & (K Units)
Figure 17. China Long-acting Anti-HIV Drug Consumption (2019-2030) & (K Units)
Figure 18. Europe Long-acting Anti-HIV Drug Consumption (2019-2030) & (K Units)
Figure 19. Japan Long-acting Anti-HIV Drug Consumption (2019-2030) & (K Units)
Figure 20. South Korea Long-acting Anti-HIV Drug Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Long-acting Anti-HIV Drug Consumption (2019-2030) & (K Units)
Figure 22. India Long-acting Anti-HIV Drug Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Long-acting Anti-HIV Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Long-acting Anti-HIV Drug Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Long-acting Anti-HIV Drug Markets in 2023
Figure 26. United States VS China: Long-acting Anti-HIV Drug Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Long-acting Anti-HIV Drug Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Long-acting Anti-HIV Drug Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Long-acting Anti-HIV Drug Production Market Share 2023
Figure 30. China Based Manufacturers Long-acting Anti-HIV Drug Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Long-acting Anti-HIV Drug Production Market Share 2023
Figure 32. World Long-acting Anti-HIV Drug Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Long-acting Anti-HIV Drug Production Value Market Share by Type in 2023
Figure 34. CAB Long-acting Injection
Figure 35. RPV Long-acting Injection
Figure 36. World Long-acting Anti-HIV Drug Production Market Share by Type (2019-2030)
Figure 37. World Long-acting Anti-HIV Drug Production Value Market Share by Type (2019-2030)
Figure 38. World Long-acting Anti-HIV Drug Average Price by Type (2019-2030) & (US$/Unit)
Figure 39. World Long-acting Anti-HIV Drug Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Long-acting Anti-HIV Drug Production Value Market Share by Application in 2023
Figure 41. Hospital
Figure 42. Clinic
Figure 43. Others
Figure 44. World Long-acting Anti-HIV Drug Production Market Share by Application (2019-2030)
Figure 45. World Long-acting Anti-HIV Drug Production Value Market Share by Application (2019-2030)
Figure 46. World Long-acting Anti-HIV Drug Average Price by Application (2019-2030) & (US$/Unit)
Figure 47. Long-acting Anti-HIV Drug Industry Chain
Figure 48. Long-acting Anti-HIV Drug Procurement Model
Figure 49. Long-acting Anti-HIV Drug Sales Model
Figure 50. Long-acting Anti-HIV Drug Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Table 1. World Long-acting Anti-HIV Drug Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Long-acting Anti-HIV Drug Production Value by Region (2019-2024) & (USD Million)
Table 3. World Long-acting Anti-HIV Drug Production Value by Region (2025-2030) & (USD Million)
Table 4. World Long-acting Anti-HIV Drug Production Value Market Share by Region (2019-2024)
Table 5. World Long-acting Anti-HIV Drug Production Value Market Share by Region (2025-2030)
Table 6. World Long-acting Anti-HIV Drug Production by Region (2019-2024) & (K Units)
Table 7. World Long-acting Anti-HIV Drug Production by Region (2025-2030) & (K Units)
Table 8. World Long-acting Anti-HIV Drug Production Market Share by Region (2019-2024)
Table 9. World Long-acting Anti-HIV Drug Production Market Share by Region (2025-2030)
Table 10. World Long-acting Anti-HIV Drug Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Long-acting Anti-HIV Drug Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Long-acting Anti-HIV Drug Major Market Trends
Table 13. World Long-acting Anti-HIV Drug Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Long-acting Anti-HIV Drug Consumption by Region (2019-2024) & (K Units)
Table 15. World Long-acting Anti-HIV Drug Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Long-acting Anti-HIV Drug Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Long-acting Anti-HIV Drug Producers in 2023
Table 18. World Long-acting Anti-HIV Drug Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Long-acting Anti-HIV Drug Producers in 2023
Table 20. World Long-acting Anti-HIV Drug Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Long-acting Anti-HIV Drug Company Evaluation Quadrant
Table 22. World Long-acting Anti-HIV Drug Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Long-acting Anti-HIV Drug Production Site of Key Manufacturer
Table 24. Long-acting Anti-HIV Drug Market: Company Product Type Footprint
Table 25. Long-acting Anti-HIV Drug Market: Company Product Application Footprint
Table 26. Long-acting Anti-HIV Drug Competitive Factors
Table 27. Long-acting Anti-HIV Drug New Entrant and Capacity Expansion Plans
Table 28. Long-acting Anti-HIV Drug Mergers & Acquisitions Activity
Table 29. United States VS China Long-acting Anti-HIV Drug Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Long-acting Anti-HIV Drug Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Long-acting Anti-HIV Drug Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Long-acting Anti-HIV Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Long-acting Anti-HIV Drug Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Long-acting Anti-HIV Drug Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Long-acting Anti-HIV Drug Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Long-acting Anti-HIV Drug Production Market Share (2019-2024)
Table 37. China Based Long-acting Anti-HIV Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Long-acting Anti-HIV Drug Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Long-acting Anti-HIV Drug Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Long-acting Anti-HIV Drug Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Long-acting Anti-HIV Drug Production Market Share (2019-2024)
Table 42. Rest of World Based Long-acting Anti-HIV Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Long-acting Anti-HIV Drug Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Long-acting Anti-HIV Drug Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Long-acting Anti-HIV Drug Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Long-acting Anti-HIV Drug Production Market Share (2019-2024)
Table 47. World Long-acting Anti-HIV Drug Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Long-acting Anti-HIV Drug Production by Type (2019-2024) & (K Units)
Table 49. World Long-acting Anti-HIV Drug Production by Type (2025-2030) & (K Units)
Table 50. World Long-acting Anti-HIV Drug Production Value by Type (2019-2024) & (USD Million)
Table 51. World Long-acting Anti-HIV Drug Production Value by Type (2025-2030) & (USD Million)
Table 52. World Long-acting Anti-HIV Drug Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Long-acting Anti-HIV Drug Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Long-acting Anti-HIV Drug Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Long-acting Anti-HIV Drug Production by Application (2019-2024) & (K Units)
Table 56. World Long-acting Anti-HIV Drug Production by Application (2025-2030) & (K Units)
Table 57. World Long-acting Anti-HIV Drug Production Value by Application (2019-2024) & (USD Million)
Table 58. World Long-acting Anti-HIV Drug Production Value by Application (2025-2030) & (USD Million)
Table 59. World Long-acting Anti-HIV Drug Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Long-acting Anti-HIV Drug Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Gilead Basic Information, Manufacturing Base and Competitors
Table 62. Gilead Major Business
Table 63. Gilead Long-acting Anti-HIV Drug Product and Services
Table 64. Gilead Long-acting Anti-HIV Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Gilead Recent Developments/Updates
Table 66. Gilead Competitive Strengths & Weaknesses
Table 67. ViiV Healthcare Basic Information, Manufacturing Base and Competitors
Table 68. ViiV Healthcare Major Business
Table 69. ViiV Healthcare Long-acting Anti-HIV Drug Product and Services
Table 70. ViiV Healthcare Long-acting Anti-HIV Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. ViiV Healthcare Recent Developments/Updates
Table 72. ViiV Healthcare Competitive Strengths & Weaknesses
Table 73. Janssen Basic Information, Manufacturing Base and Competitors
Table 74. Janssen Major Business
Table 75. Janssen Long-acting Anti-HIV Drug Product and Services
Table 76. Janssen Long-acting Anti-HIV Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Janssen Recent Developments/Updates
Table 78. Janssen Competitive Strengths & Weaknesses
Table 79. Tibotec Basic Information, Manufacturing Base and Competitors
Table 80. Tibotec Major Business
Table 81. Tibotec Long-acting Anti-HIV Drug Product and Services
Table 82. Tibotec Long-acting Anti-HIV Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Tibotec Recent Developments/Updates
Table 84. Tibotec Competitive Strengths & Weaknesses
Table 85. Cipla Basic Information, Manufacturing Base and Competitors
Table 86. Cipla Major Business
Table 87. Cipla Long-acting Anti-HIV Drug Product and Services
Table 88. Cipla Long-acting Anti-HIV Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Cipla Recent Developments/Updates
Table 90. Frontier Biopharmaceutical (Nanjing) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 91. Frontier Biopharmaceutical (Nanjing) Co., Ltd. Major Business
Table 92. Frontier Biopharmaceutical (Nanjing) Co., Ltd. Long-acting Anti-HIV Drug Product and Services
Table 93. Frontier Biopharmaceutical (Nanjing) Co., Ltd. Long-acting Anti-HIV Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Global Key Players of Long-acting Anti-HIV Drug Upstream (Raw Materials)
Table 95. Long-acting Anti-HIV Drug Typical Customers
Table 96. Long-acting Anti-HIV Drug Typical Distributors
LIST OF FIGURE
Figure 1. Long-acting Anti-HIV Drug Picture
Figure 2. World Long-acting Anti-HIV Drug Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Long-acting Anti-HIV Drug Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Long-acting Anti-HIV Drug Production (2019-2030) & (K Units)
Figure 5. World Long-acting Anti-HIV Drug Average Price (2019-2030) & (US$/Unit)
Figure 6. World Long-acting Anti-HIV Drug Production Value Market Share by Region (2019-2030)
Figure 7. World Long-acting Anti-HIV Drug Production Market Share by Region (2019-2030)
Figure 8. North America Long-acting Anti-HIV Drug Production (2019-2030) & (K Units)
Figure 9. Europe Long-acting Anti-HIV Drug Production (2019-2030) & (K Units)
Figure 10. China Long-acting Anti-HIV Drug Production (2019-2030) & (K Units)
Figure 11. Japan Long-acting Anti-HIV Drug Production (2019-2030) & (K Units)
Figure 12. Long-acting Anti-HIV Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Long-acting Anti-HIV Drug Consumption (2019-2030) & (K Units)
Figure 15. World Long-acting Anti-HIV Drug Consumption Market Share by Region (2019-2030)
Figure 16. United States Long-acting Anti-HIV Drug Consumption (2019-2030) & (K Units)
Figure 17. China Long-acting Anti-HIV Drug Consumption (2019-2030) & (K Units)
Figure 18. Europe Long-acting Anti-HIV Drug Consumption (2019-2030) & (K Units)
Figure 19. Japan Long-acting Anti-HIV Drug Consumption (2019-2030) & (K Units)
Figure 20. South Korea Long-acting Anti-HIV Drug Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Long-acting Anti-HIV Drug Consumption (2019-2030) & (K Units)
Figure 22. India Long-acting Anti-HIV Drug Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Long-acting Anti-HIV Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Long-acting Anti-HIV Drug Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Long-acting Anti-HIV Drug Markets in 2023
Figure 26. United States VS China: Long-acting Anti-HIV Drug Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Long-acting Anti-HIV Drug Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Long-acting Anti-HIV Drug Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Long-acting Anti-HIV Drug Production Market Share 2023
Figure 30. China Based Manufacturers Long-acting Anti-HIV Drug Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Long-acting Anti-HIV Drug Production Market Share 2023
Figure 32. World Long-acting Anti-HIV Drug Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Long-acting Anti-HIV Drug Production Value Market Share by Type in 2023
Figure 34. CAB Long-acting Injection
Figure 35. RPV Long-acting Injection
Figure 36. World Long-acting Anti-HIV Drug Production Market Share by Type (2019-2030)
Figure 37. World Long-acting Anti-HIV Drug Production Value Market Share by Type (2019-2030)
Figure 38. World Long-acting Anti-HIV Drug Average Price by Type (2019-2030) & (US$/Unit)
Figure 39. World Long-acting Anti-HIV Drug Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Long-acting Anti-HIV Drug Production Value Market Share by Application in 2023
Figure 41. Hospital
Figure 42. Clinic
Figure 43. Others
Figure 44. World Long-acting Anti-HIV Drug Production Market Share by Application (2019-2030)
Figure 45. World Long-acting Anti-HIV Drug Production Value Market Share by Application (2019-2030)
Figure 46. World Long-acting Anti-HIV Drug Average Price by Application (2019-2030) & (US$/Unit)
Figure 47. Long-acting Anti-HIV Drug Industry Chain
Figure 48. Long-acting Anti-HIV Drug Procurement Model
Figure 49. Long-acting Anti-HIV Drug Sales Model
Figure 50. Long-acting Anti-HIV Drug Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
